Apatinib treatment may improve survival outcomes of patients with hepatitis B virus-related sorafenib-resistant hepatocellular carcinoma

AIMS: This study aimed to (a) assess the effectiveness and safety of apatinib as a subsequent treatment for patients with sorafenib-resistant hepatocellular carcinoma (HCC), and (b) identify the clinical factors influencing their treatment outcomes. METHODS: The electronic medical records of consecu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Adv Med Oncol
Hlavní autoři: Zhang, Yingqiang, Huang, Guihua, Miao, Hongfei, Song, Ze, Zhang, Xiaoying, Fan, Wenzhe, Wang, Yu, Li, Jiaping, Chen, Yong
Médium: Artigo
Jazyk:Inglês
Vydáno: SAGE Publications 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7378719/
https://ncbi.nlm.nih.gov/pubmed/32754228
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920937422
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky